Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Semaglutide, Ozempic & Wegovy: semaglutide is the GLP-1 receptor agonist peptide sold pharmaceutically under the brand names Ozempic and Wegovy (and orally as Rybelsus) by Novo Nordisk
Beginning in 2024, the FDA expanded Wegovys approval to include reducing cardiovascular risk in adults with existing heart disease
Side effects are related to the drugs mechanism rather than the delivery method
Cutting-Edge Treatments: As part of our commitment to offering the most effective, evidence-based care, we provide the latest weight loss treatments and technologies, including GLP-1 inhibitors like Ozempic and Wegovy, that are proven to help people lose weight and improve their health
